Opinion: How to turn the next crisis into something routine
By Angel Iscovich We are just emerging from a once-in-a-generation crisis. COVID-19 has disrupted not just nations, but the world. We can view events as Pre-Pandemic and Post-Pandemic. To say the coronavirus has also disrupted businesses would be the understatement of the year. Or decade. We have witnessed the destruction of companies and industries that Read More →
Opinion: When it comes to vaccines, trust the real experts
By Frank Kalman When it comes to facing a deadly disease, who you are relying on for advice truly matters! According to Dr. Philip Landrigan — epidemiologist and pediatrician and one of the world’s leading advocates of children’s health — children today live longer, healthier lives and suffer less disease than children at any previous Read More →
Amgen to buy biotech startup TeneoBio
Amgen announced July 27 that it plans to buy a privately held Bay Area biotech company called TeneoBio in an all-cash deal worth as much as $2.5 billion. The deal is expected to close in the second half of this year and calls for Amgen to pay $900 million up front for all outstanding shares Read More →
Dubroff: With delta variant spreading, it’s time to get serious about vaccines
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Deal for new Santa Paula Hospital land ‘a long time in the making’
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Speedy cancer care matters, now more than ever, Thousand Oaks’ Rabble Health finds in new study
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Takeda expansion is latest coup for Conejo Valley pharma industry
Takeda Pharmaceuticals, a Japanese company with major operations in the Conejo Valley, will expand its facility in Thousand Oaks, investing $126 million to build out the manufacturing operations to support new product lines. The Takeda team, alongside the mayor of Thousand Oaks, Claudia Bill-de la Peña, is scheduled to hold a groundbreaking ceremony for the Read More →
